| huCaspase-6 in complex with inhibitor 2a | |
Heteromer
| 30-292 | 4×CL; 6×EDO; 2×US9; 1×PEG; |
| Assess |
| huCaspase-6 in complex with inhibitor 3a | |
Heteromer
| 30-292 | 2×UCI; 1×EDO; |
| Assess |
| Caspase-6 in complex with Z-VAD-FMK inhibitor | |
Heteromer
| 31-292 | |
| Assess |
| Crystal structure of apo-caspase-6 at physiological pH | |
Heteromer
| 31-291 | |
| Assess |
| Zinc-mediated allosteric inhibiton of caspase-6 | | homo-4-mer | 27-293 | 4×ZN; |
| Assess |
| Allosteric peptides that bind to a caspase zymogen and mediate caspase tetramerization | | homo-4-mer | 30-292 | 2×PO4; |
| Assess |
| Crystal structure of human ligand-free mature caspase-6 with intersubunit linker attached | | homo-4-mer | 31-293 | |
| Assess |
| Crystal structure of human ligand-free mature caspase-6 | | homo-4-mer | 32-291 | |
| Assess |
| Tailoring Small Molecules for an Allosteric Site on Procaspase-6 | | homo-2-mer | 24-292 | 1×2J6; 6×PO4; |
| Assess |
| Tailoring Small Molecules for an Allosteric Site on Procaspase-6 | | homo-2-mer | 25-292 | 5×PO4; 1×2GQ; |
| Assess |
| Tailoring Small Molecules for an Allosteric Site on Procaspase-6 | | homo-2-mer | 25-292 | 9×PO4; 1×2J7; |
| Assess |
| Tailoring Small Molecules for an Allosteric Site on Procaspase-6 | | homo-2-mer | 25-292 | 1×2J5; 6×PO4; |
| Assess |
| Tailoring Small Molecules for an Allosteric Site on Procaspase-6: Cpd1 | | homo-2-mer | 25-292 | 1×2FQ; 2×PO4; 2×MPD; |
| Assess |
| Tailoring Small Molecules for an Allosteric Site on Procaspase-6 | | homo-2-mer | 25-292 | 1×2GQ; 5×PO4; |
| Assess |
| Tailoring Small Molecules for an Allosteric Site on Procaspase-6 | | homo-2-mer | 25-292 | 4×PO4; 1×2GQ; |
| Assess |
| Compound 5 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×XM6; 3×EDO; 1×PEG; |
| Assess |
| Human caspase-6 E35K | | homo-2-mer | 30-293 | |
| Assess |
| Compound 11 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×XMX; |
| Assess |
| Compound 1 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×2J6; 1×CL; |
| Assess |
| Compound 21 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×XNK; |
| Assess |
| Compound 19 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×XN5; |
| Assess |
| Compound 8 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×XML; |
| Assess |
| Compound 20 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×XN9; |
| Assess |
| Compound 10 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×XMR; |
| Assess |
| Compound 7 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×XOW; |
| Assess |
| Compound 3 bound to procaspase-6 | | homo-2-mer | 30-293 | 1×XLW; |
| Assess |
| Crystal Structure of Ligand Free Human Caspase-6 | | homo-2-mer | 31-293 | |
| Assess |
| Crystal Structure of caspase-6 inactivation mutation | | homo-2-mer | 30-292 | |
| Assess |
| Human caspase-6 A109T | | homo-2-mer | 30-292 | |
| Assess |
| Phosphorylation regulates assembly of the caspase-6 substrate-binding groove | | homo-2-mer | 30-292 | |
| Assess |
| Crystal structure of active caspase-6 bound with Ac-VEID-CHO solved by As-SAD | | homo-2-mer | 31-292 | 8×CAC; 1×ACT; 1×MG; |
| Assess |
| Mechanistic and Structural Understanding of Uncompetitive Inhibitors of Caspase-6 | | homo-2-mer | 30-291 | 2×4HV; |
| Assess |
| Inhibition of caspase-6 activity by single mutation outside the active site | | homo-2-mer | 31-292 | |
| Assess |
| Crystal structure of full-length caspase-6 zymogen | | homo-2-mer | 31-292 | |
| Assess |
| Crystal structure of Caspase-6 zymogen | | homo-2-mer | 31-292 | |
| Assess |
| Crystal structure of active caspase-6 in complex with Ac-VEID-CHO inhibitor | | homo-2-mer | 31-291 | |
| Assess |
| Crystal structure of active caspase-6 bound with Ac-VEID-CHO | | monomer | 31-291 | 4×CAC; |
| Assess |